Fate Therapeutics, Inc. (FATE) Stock Price History
Historical prices from 2013 to 2026
Loading 10-year price history...
FATE Historical Performance
Short-Term Returns
FATE Stock Price Trajectory (2013–2026)
As of May 7, 2026, Fate Therapeutics, Inc. (FATE) trades at $2.29, representing a +139.1% return over the past year. The stock has delivered a -97.0% total return over five years (-50.4% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $121.16 on January 14, 2021. From this peak, FATE has corrected -98.1%, currently trading 91% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers CRSP (+66.1% 1Y), NTLA (+91.0% 1Y), and BEAM (+102.2% 1Y), FATE has outperformed the peer group average. Compare FATE vs CRSP →
FATE Historical Price Data (2013–2026)
Showing 30 of 3,169 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 2.29 | 2.41 | 2.17 | 2.29 | 5.86M | -2.97% |
| 2026-05-05 | 2.05 | 2.36 | 1.98 | 2.36 | 10.64M | +31.11% |
| 2026-05-04 | 1.53 | 1.88 | 1.53 | 1.80 | 8.47M | +17.65% |
| 2026-05-01 | 1.25 | 1.59 | 1.24 | 1.53 | 5.00M | +22.40% |
| 2026-04-30 | 1.24 | 1.28 | 1.22 | 1.25 | 741K | +0.81% |
| 2026-04-29 | 1.28 | 1.30 | 1.22 | 1.24 | 906K | -4.62% |
| 2026-04-28 | 1.31 | 1.33 | 1.28 | 1.30 | 737K | -0.76% |
| 2026-04-27 | 1.36 | 1.38 | 1.30 | 1.31 | 1.18M | -1.50% |
| 2026-04-24 | 1.32 | 1.34 | 1.29 | 1.33 | 877K | +0.76% |
| 2026-04-23 | 1.36 | 1.39 | 1.30 | 1.32 | 979K | -3.65% |
| 2026-04-22 | 1.39 | 1.40 | 1.36 | 1.37 | 701K | +1.48% |
| 2026-04-21 | 1.40 | 1.40 | 1.32 | 1.35 | 1.13M | -2.88% |
| 2026-04-20 | 1.38 | 1.41 | 1.35 | 1.39 | 1.19M | 0.00% |
| 2026-04-17 | 1.40 | 1.42 | 1.35 | 1.39 | 2.01M | +1.46% |
| 2026-04-16 | 1.28 | 1.39 | 1.28 | 1.37 | 1.21M | +6.20% |
| 2026-04-15 | 1.35 | 1.36 | 1.26 | 1.29 | 1.37M | -3.73% |
| 2026-04-14 | 1.34 | 1.42 | 1.33 | 1.34 | 1.57M | +2.29% |
| 2026-04-13 | 1.25 | 1.45 | 1.25 | 1.31 | 2.27M | +5.65% |
| 2026-04-10 | 1.28 | 1.28 | 1.22 | 1.24 | 1.21M | -2.36% |
| 2026-04-09 | 1.19 | 1.29 | 1.18 | 1.27 | 1.36M | +7.63% |
| 2026-04-08 | 1.22 | 1.23 | 1.16 | 1.18 | 899K | +2.61% |
| 2026-04-07 | 1.19 | 1.21 | 1.14 | 1.15 | 1.19M | -3.36% |
| 2026-04-06 | 1.23 | 1.25 | 1.19 | 1.19 | 846K | -2.46% |
| 2026-04-02 | 1.19 | 1.24 | 1.18 | 1.22 | 657K | -1.61% |
| 2026-04-01 | 1.22 | 1.26 | 1.22 | 1.24 | 701K | +3.33% |
| 2026-03-31 | 1.16 | 1.24 | 1.15 | 1.20 | 1.49M | +6.19% |
| 2026-03-30 | 1.15 | 1.17 | 1.10 | 1.13 | 807K | -3.42% |
| 2026-03-27 | 1.22 | 1.23 | 1.14 | 1.17 | 1.16M | -4.88% |
| 2026-03-26 | 1.20 | 1.31 | 1.20 | 1.23 | 1.22M | +0.82% |
| 2026-03-25 | 1.15 | 1.28 | 1.15 | 1.22 | 2.03M | +7.96% |
See FATE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FATE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare FATE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonFATE — Frequently Asked Questions
Quick answers to the most common questions about buying FATE stock.
How has FATE stock performed recently?
FATE returned +139.1% over the past year, beating its 5-year annualized CAGR of -50.4%. The stock trades above its 200-day moving average, confirming the uptrend.
What is FATE's all-time high price?
Fate Therapeutics, Inc. reached $121.16 on 2021-01-14. The 52-week high is $2.41. Current 1-year return of +139.1% places the stock closer to historical peaks.
Where can I download FATE historical price data?
This page provides FATE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2013-2026, downloadable in CSV format.